Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuVascular Technologies
Ashland, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
NuVascular Technologies is in pre-clinical and early clinical discussions with the FDA, focusing on a nanotechnology-based electrospinning platform to develop biologically active, drug-eluting vascular grafts and other medical devices. Key devices, like the NuSpun artificial blood vessel and HARBOR Occlusion Device for brain aneurysm, are in development; the HARBOR device is in pilot clinical trials evaluating safety and efficacy endpoints for aneurysm occlusion.
- Therapeutic areas
- NeurologyNephrologyCardiovascular
- Modalities
- DeviceNanoparticleBiologic
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on NuVascular Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NuVascular Technologies.